Sign in

CIK 0001600620 · Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981231763
Phone
250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 8-K Event Acquisition or sale completed
  7. SC TO-T/A Deal Tender Offer Statement
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. DEF 14A Proxy Proxy Statement
  11. SC TO-T Deal Tender Offer Statement
  12. 8-K Event Material agreement · Regulation FD disclosure
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. 8-K Event Executive or director change
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. SCHEDULE 13D/A Stake Beneficial Ownership Report
  20. 4 Insider Changes in Ownership

Page 2 of 31 · 615 filings